Since tumor-reactive CD4+ and CD8+ T cells both secrete CXCL13, it is likely that this chemokine plays a key role in controlling the recruitment of immune cells to the TME as well as in the spatial organization of the immune cell infiltrate within the tumor. Here, CD4 is linked to neoplasm.